Industry
Altamira Therapeutics Ltd [CYTO] Is Currently 19.58 above its 200 Period Moving Avg: What Does This Mean?
Altamira Therapeutics Ltd [NASDAQ: CYTO] price surged by 19.58 percent to reach at $0.28. The one-year CYTO stock forecast points to a potential upside of 99.4. The average equity rating for CYTO stock is currently 1.00, trading closer to a bullish pattern in the stock
